Tapewire

Nasdaq · USD

PTCT

PTC THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
3803
SEC CIK
0001070081
Parsed reports
477

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025039
Dec 2025021
Jan 2026042
Feb 2026014
Mar 202606
Apr 202607
May 2026010
Jun 2026018
Jul 2026020
Aug 2026012
Sep 202608
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 09, 2024 Filed Jan 10, 2024 21:06 UTC
Golden Lee ScottCHIEF MEDICAL OFFICER
SaleCommon Stock 1,225 $29.01 $35,543.13
Disclosure

SEC source: 0001415889-24-000913 · form4-01102024_090125.xml · nonDerivative · entry 2

Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,914

F3 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs and the vesting of 3,539 RSUs from January 7, 2022 grants totaling14,155 RSUs.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:04 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,938 $29.01 $56,230.68
Disclosure

SEC source: 0001415889-24-000910 · form4-01102024_090136.xml · nonDerivative · entry 2

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,983

F2 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:03 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 100 $29.01 $2,901.48
Disclosure

SEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 4

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 3,734

F6 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs and the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:03 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,521 $29.01 $44,131.51
Disclosure

SEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 3

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,820

F5 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:11 UTC
Utter Christine MarieSVP, FINANCE & CAO
SaleCommon Stock 1,188 $28.64 $34,024.68
Disclosure

SEC source: 0001415889-24-000921 · form4-01102024_090117.xml · nonDerivative · entry 1

Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,499

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs.

F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:10 UTC SaleCommon Stock 1,500 $27.81 $41,715.00
Disclosure

SEC source: 0001415889-24-000919 · form4-01102024_090117.xml · nonDerivative · entry 1

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,266

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023, to satisfy tax obligations in connection with the vesting of 4,664 restricted stock units from a January 5, 2023 grant of 8,000 restricted stock units.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:09 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 1,569 $28.64 $44,936.63
Disclosure

SEC source: 0001415889-24-000917 · form4-01102024_090157.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,612

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 5, 2023 grant of 18,000 RSUs.

F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:08 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 2,237 $28.64 $64,068.35
Disclosure

SEC source: 0001415889-24-000915 · form4-01102024_090152.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,918

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:06 UTC
Golden Lee ScottCHIEF MEDICAL OFFICER
SaleCommon Stock 775 $28.64 $22,196.23
Disclosure

SEC source: 0001415889-24-000913 · form4-01102024_090125.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,139

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,666 RSUs from a January 5, 2023 grant of 10,640 RSUs.

F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:04 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,457 $28.64 $41,728.92
Disclosure

SEC source: 0001415889-24-000910 · form4-01102024_090136.xml · nonDerivative · entry 1

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,921

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:03 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 53 $28.64 $1,517.94
Disclosure

SEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 2

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 3,834

F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs.

F4 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 21:03 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,236 $28.64 $35,399.41
Disclosure

SEC source: 0001415889-24-000908 · form4-01102024_090133.xml · nonDerivative · entry 1

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,341

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.

F2 · balance_after: Includes 327 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023 and 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 21:29 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 10,107 $27.15 $274,392.92
Disclosure

SEC source: 0001415889-24-000854 · form4-01092024_090130.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,155

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs.

F2 · balance_after: Includes 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023.

Read SEC document
December 28, 2023 Filed Dec 28, 2023 22:12 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-016992 · form4-12282023_101229.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,961

F1 · shares: Restricted stock unit granted on December 28, 2023 that vests in four equal installments over four years, commencing on December 29, 2023.

F2 · balance_after: Includes 316 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023.

Read SEC document
December 12, 2023 Filed Dec 14, 2023 21:38 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
PurchaseCommon Stock 7,700 $25.81 $198,736.23
Disclosure

SEC source: 0001415889-23-016478 · form4-12142023_091224.xml · nonDerivative · entry 1

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,700

F1 · price: This price represents the weighted average price of purchase transactions that were executed in multiple trades at prices ranging from $25.77 to $25.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:02 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,666 $27.85 Strike: $27.85 $129,948.10
Disclosure

SEC source: 0001415889-23-013116 · form4-09082023_080934.xml · derivative · entry 6

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,334

Underlying: Common Stock · 4,666 shares

Expires 2032-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:02 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $27.85 Strike: $27.85 $194,950.00
Disclosure

SEC source: 0001415889-23-013116 · form4-09082023_080934.xml · derivative · entry 5

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2032-06-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Currently exercisable.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:02 UTC SaleCommon Stock 4,666 $39.79 $185,672.27
Disclosure

SEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 4

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,067

F1 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:02 UTC Exercise / conversionCommon Stock 4,666 $27.85 $129,948.10
Disclosure

SEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 3

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:02 UTC SaleCommon Stock 7,000 $39.90 $279,300.00
Disclosure

SEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 2

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,067

Read SEC document
September 06, 2023 Filed Sep 8, 2023 20:02 UTC Exercise / conversionCommon Stock 7,000 $27.85 $194,950.00
Disclosure

SEC source: 0001415889-23-013116 · form4-09082023_080934.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 20:51 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $39.82 $0.00
Disclosure

SEC source: 0001415889-23-011167 · form4-07172023_080747.xml · derivative · entry 2

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2033-07-12

F2 · derivative.exercise_date: This option was granted on July 13, 2023, and vests over four years, with 25% of the shares underlying the option vesting on July 13, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 13, 2024.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 20:51 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
GrantCommon Stock 26,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-011167 · form4-07172023_080747.xml · nonDerivative · entry 1

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

F1 · shares: Restricted stock units granted on July 13, 2023 that vest in four equal installments over four years, commencing on July 13, 2024.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:03 UTC SaleCommon Stock 1,000 $44.86 $44,860.00
Disclosure

SEC source: 0001415889-23-009501 · form4-06092023_080626.xml · nonDerivative · entry 1

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,766

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023, to satisfy tax obligations in connection with the vesting of 3,334 restricted stock units from a January 5, 2023 grant of 8,000 restricted stock units.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 20:07 UTC GrantStock Option (Right to Buy) · Derivative 5,834 $0.00 Strike: $45.02 $0.00
Disclosure

SEC source: 0001415889-23-009356 · form4-06072023_080617.xml · derivative · entry 4

Bell William F. Jr. · CIK 0001980122 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,834

Underlying: Common Stock · 5,834 shares

Expires 2033-06-05

F4 · derivative.exercise_date: This option was granted on June 6, 2023 and vests over seven approximately equal monthly installments, commencing on July 5, 2023.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 20:07 UTC GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $45.02 $0.00
Disclosure

SEC source: 0001415889-23-009356 · form4-06072023_080617.xml · derivative · entry 3

Bell William F. Jr. · CIK 0001980122 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-06-05

F3 · derivative.exercise_date: This option was granted on June 6, 2023 and vests over thirty-six approximately equal monthly installments, commencing on July 6, 2023.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 20:07 UTC GrantCommon Stock 2,333 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-009356 · form4-06072023_080617.xml · nonDerivative · entry 2

Bell William F. Jr. · CIK 0001980122 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,333

F2 · shares: Restricted stock units granted on June 6, 2023 that vest on January 5, 2024.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 20:07 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-009356 · form4-06072023_080617.xml · nonDerivative · entry 1

Bell William F. Jr. · CIK 0001980122 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

F1 · shares: Restricted stock units granted on June 6, 2023 that vest in three equal installments over three years, commencing on June 6, 2024.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 1,402 $33.63 Strike: $33.63 $47,149.26
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 18

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,650

Underlying: Common Stock · 1,402 shares

Expires 2028-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 1,093 $33.02 Strike: $33.02 $36,090.86
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 17

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,912

Underlying: Common Stock · 1,093 shares

Expires 2029-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 157 $33.63 Strike: $33.63 $5,279.91
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 16

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 837

Underlying: Common Stock · 157 shares

Expires 2028-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
SaleCommon Stock 1,402 $59.54 $83,472.00
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 12

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,200

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 1,402 $33.63 $47,149.26
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 11

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
SaleCommon Stock 1,093 $59.53 $65,068.48
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 10

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,200

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 1,093 $33.02 $36,090.86
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 9

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,293

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
SaleCommon Stock 157 $59.52 $9,344.18
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 8

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,200

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 157 $33.63 $5,279.91
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 7

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,357

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

Read SEC document
May 22, 2023 Filed May 23, 2023 20:05 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 100 $59.66 $5,966.00
Disclosure

SEC source: 0001415889-23-008568 · form4-05232023_080529.xml · nonDerivative · entry 3

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,553

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022.

Read SEC document
May 22, 2023 Filed May 23, 2023 20:05 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 1,913 $58.98 $112,825.49
Disclosure

SEC source: 0001415889-23-008568 · form4-05232023_080529.xml · nonDerivative · entry 2

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,653

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.61 to $59.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 3,948 $33.63 Strike: $33.63 $132,771.24
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 15

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,052

Underlying: Common Stock · 3,948 shares

Expires 2028-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 2,995 $33.02 Strike: $33.02 $98,894.90
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 14

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,005

Underlying: Common Stock · 2,995 shares

Expires 2029-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 173 $33.63 Strike: $33.63 $5,817.99
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · derivative · entry 13

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 994

Underlying: Common Stock · 173 shares

Expires 2028-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
SaleCommon Stock 3,948 $59.53 $235,029.57
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 6

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,200

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 3,948 $33.63 $132,771.24
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 5

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
SaleCommon Stock 2,995 $59.53 $178,302.83
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 4

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,200

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 2,995 $33.02 $98,894.90
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 3

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
SaleCommon Stock 173 $59.52 $10,297.69
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 2

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,200

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $59.50 to $59.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2023 Filed May 24, 2023 20:12 UTC
Reeve EmmaDirector
Exercise / conversionCommon Stock 173 $33.63 $5,817.99
Disclosure

SEC source: 0001415889-23-008704 · form4-05242023_080557.xml · nonDerivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,373

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:05 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 6,403 $58.96 $377,490.79
Disclosure

SEC source: 0001415889-23-008568 · form4-05232023_080529.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,566

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $59.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:04 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 788 $58.71 $46,266.87
Disclosure

SEC source: 0001415889-23-008390 · form4-05192023_080525.xml · nonDerivative · entry 3

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,969

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $59.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.